FDA product code NZW: Heparin, Vascular Access Flush
NZW is the FDA product code for heparin, vascular access flush. It is a Class II device, regulated under 21 CFR 880.5200 and reviewed by the General Hospital panel. FDA has cleared 7 510(k) submissions under NZW, from 6 different applicants. The average 510(k) review took 203 days (median 187). FDA has posted 44 recalls for NZW devices, 1 initiated in the last five years.
Definition
Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use.
Classification
| Field | Value |
|---|---|
| Device name | Heparin, Vascular Access Flush |
| Device class | Class II |
| Regulation | 21 CFR 880.5200 |
| Review panel | HO — General Hospital |
| Medical specialty | General Hospital |
| Premarket route | 510(k) |
510(k) clearances per year for NZW
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 69 |
Compare with all 510(k) review times · Search every NZW clearance
Top NZW applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Excelsior Medical Corp. | 2 | 2007-02-23 |
| Becton, Dickinson and Company | 1 | 2017-02-27 |
| Excelsior Medical Corporation | 1 | 2014-11-14 |
| App Pharmaceuticals, LLC | 1 | 2010-06-18 |
| Medefil, Inc. | 1 | 2010-02-03 |
1 more applicants have NZW clearances. See the full list in Caduvo.
Most recent NZW clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K163591 | Becton, Dickinson and Company | BD PosiFlush Heparin Lock Flush Syringe | 2017-02-27 | 69 |
| K133446 | Excelsior Medical Corporation | HEPARIN LOCK / FLUSH SYRINGES | 2014-11-14 | 367 |
| K092938 | App Pharmaceuticals, LLC | HEPARIN LOCK FLUSH SOLUTION USP, MODELS 504401, 504411, 504505, 505701, 504901, 1710 | 2010-06-18 | 267 |
| K092491 | Medefil, Inc. | MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE 1 UNIT/ML; 10 UNITS/ML; AND 100 UNITS/ML IN VARIOUS FILL SIZES | 2010-02-03 | 174 |
| K090680 | Becton, Dickinson & CO | HEPARIN LOCK FLUSH SOLUTION, USP BD POSIFLUSH HEPARIN LOCK FLUSH SYRINGE | 2009-06-10 | 86 |
Recalls for NZW devices
44 product recalls in 11 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2022-05-25.
| Year | Recalls |
|---|---|
| 2022 | 1 |
Frequently asked questions
What is FDA product code NZW?
NZW is the FDA product code for heparin, vascular access flush. It is a Class II device, regulated under 21 CFR 880.5200 and reviewed by the General Hospital panel.
What device class is NZW?
Class II, regulation 21 CFR 880.5200. Typical premarket route: 510(k).
How long does a 510(k) take for product code NZW?
Across 7 cleared submissions the average was 203 days from receipt to decision (median 187).
Which companies have the most NZW clearances?
Excelsior Medical Corp. (2); Becton, Dickinson and Company (1); Excelsior Medical Corporation (1); App Pharmaceuticals, LLC (1); Medefil, Inc. (1).
Have NZW devices been recalled?
Yes: 44 product recalls across 11 recall events; the most recent began 2022-05-25.
Next steps
- Run an FDA pathway report with predicate devices for product code NZW
- Run a recall and safety report across every NZW manufacturer
- Watch product code NZW for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All General Hospital product codes · FDA product code lookup · 510(k) database search · 510(k) review times